Advertisement

Erratum

    Published:November 30, 2022DOI:https://doi.org/10.1016/j.ajic.2022.11.017
        In the article “Novel Case of Candida auris in the Veterans Health Administration and in the state of South Carolina.” by Lucy Austin, et al. in the November issue of the American Journal of Infection Control (2022;50(11):1258-62) The author names were incorrectly listed as surname followed by given name.
        The correct author names are Lucy Austin MSN, RN, CIC; Paula Guild MN, RN, CIC; Christine Rovinski MSN, APRN; and Jailan Osman MD, MBChB, FCAP.
        This correction has been made to the online version of the article.

        Linked Article

        • Novel case of Candida auris in the Veterans Health Administration and in the state of South Carolina
          American Journal of Infection ControlVol. 50Issue 11
          • Preview
            Candida auris (C. auris) is a multidrug resistant fungus identified by the Centers for Disease Control and Prevention (CDC) as an emerging pathogen with a rating of “Serious” on the CDC's Threat Scale.1 Some C. auris strains are treated with multiple antifungal therapies, however, there are C. auris strains that are resistant to all 3 available classes of antifungals. More than 1 in 3 patients expire within 1 month of diagnosis of invasive C. auris infection.2 C. auris was first reported in 2009 in Japan3 in an external ear culture and later in the same year South Korea reported additional C.
          • Full-Text
          • PDF